Category: “Dear Doctor” Letters
-
Health Canada Issues Ketek MedEffect Alert In Early September 2007
Antibiotic Ketek Restricted To Certain Types Of Pneumonia; No Longer Used For Sinusitis, Bronchitis, Tonsillitis, Pharyngitis (Posted by Tom Lamb at DrugInjuryWatch.com) On September 5, 2007 Health Canada issued by email a MedEffect alert…
-
Parkinson’s Disease Drug Permax Ordered Off The Market By Health Canada
Permax Was Voluntarily Withdrawn From the U.S. Market Earlier This Year At The Insistence of FDA (Posted by Tom Lamb at DrugInjuryWatch.com) As you may recall, the Parkinson disease drug Permax was voluntarily withdrawn…
-
Drug Safety Update: A Promising New Monthly Electronic Bulletin From The UK’s Drug Agency
First Issue Includes Updated Advice Regarding Dostinex; Now A Second-Line Treatment Due To Increased Risk Of Serious Heart Valve Damage (Posted by Tom Lamb at DrugInjuryWatch.com) In the United Kingdom (UK) the Medicines and…
-
Sanofi-Aventis Sends “Dear Doctor” Letter Regarding Antibiotic Ketek In Late March 2007
The Letter Concerns Black-Box Warning, Prescribing Changes, And Patient Medication Guide Announced Back In Mid-February 2007 (Posted by Tom Lamb at DrugInjuryWatch.com) On March 26, 2007 the FDA announced that a so-called "Dear Doctor"…
-
Procrit, Epogen, And Aranesp: New “Black Box” Warnings Only First Part Of FDA’s Safety Re-evaluation
Popular Anemia Drugs Have Increased Risk Of Death, Blood Clots, Strokes, And Heart Attacks, Especially In Context Of Off-label Prescribing And Use (Posted by Tom Lamb at DrugInjuryWatch.com) On March 9, 2007 the FDA…
-
New Birth Control Patch Warnings In Canada About Being Overweight, Sauna Or Whirlpool Heat
No Similar Changes To Ortho Evra Label In U.S. As Of Early December 2006 On November 23, 2006 Health Canada released a drug safety alert — which consisted of a so-called "Dear Doctor" letter…
-
New Warning About Severe Liver Problems Due To Ketek
Hepatotoxicity Risks Noted In September 2006 "Dear Doctor" Letter On October 4, 2006 Health Canada issued a MedEffect alert to let doctors and patients know that the drug company Sanofi-aventis Canada is updating its…
-
FDA Approves New, Stronger Warnings For ADHD Drugs
Sudden Deaths, Strokes, And Heart Attacks In Adults At Usual Doses Several drugs to treat attention deficit hyperactivity disorder (ADHD) — including GlaxoSmithKline (GSK) Plc’s Dexedrine, Novartis AG’s Ritalin, Johnson & Johnson’s Concerta, and…
-
Anti-Epileptic Drugs Associated With Birth Defects And Fetal Death
Study Looks At Depakote, Dilantin, Tegretol, And Lamictal An August 8, 2006 article in the Los Angeles Times (LA Times) reports about a recent study involving four popular epilepsy drugs which found that one…
-
Ketek Allegedly “More Toxic Than Most Other Drugs”
Dr. David Graham At FDA Wants An "Immediate Withdrawal" Of Ketek On the morning of July 19, 2006 a National Public Radio (NPR) news piece about Ketek brought our attention back to this increasingly…